Serum 25-hydroxyvitamin D, liver enzymes and FIB-4 fibrosis risk: a statistically robust but clinically negligible association from 31,607 adult laboratory records
This study of 31,607 adult laboratory records reveals that while low serum 25-hydroxyvitamin D is statistically associated with elevated liver enzymes and FIB-4 scores, the relationship is largely explained by confounding factors like age and kidney function, rendering the clinical impact negligible.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, a persistent pattern has caught the eye of doctors and researchers: people with chronic liver problems often have low levels of vitamin D in their blood. This observation is so common that it has sparked a hopeful theory. If low vitamin D is linked to liver damage, perhaps taking supplements could heal the liver or prevent scarring. The logic seemed sound, especially since vitamin D receptors are found in liver cells and can influence how those cells behave in animal studies. However, when scientists have tested this idea in large groups of people, the results have been confusing. Some studies show a link, while others, including major clinical trials, find that giving vitamin D to patients does not actually improve their liver health. This gap between what is seen in a snapshot of a patient's health and what happens when you try to change it has left the medical community wondering: is low vitamin D a cause of liver trouble, or is it simply a sign that someone is generally unwell?
A team of researchers in Slovenia set out to settle this question by looking at a massive collection of real-world medical data. They examined the records of over 31,000 adult patients who had their blood tested for both vitamin D and a full panel of liver enzymes between 2014 and 2023. Their goal was to measure exactly how strong the connection is between vitamin D levels and the risk of liver scarring, a condition known as fibrosis. They used a standard scoring system called FIB-4, which combines a patient's age with specific blood test results to estimate the likelihood of liver damage. By analyzing such a large number of records, they could see not just if a link existed, but how big it really was, and whether it held up when they accounted for other factors like age, sex, and overall health.
The researchers found that the link between low vitamin D and liver problems is real, but it is incredibly weak. In their data, lower vitamin D levels were indeed associated with slightly higher liver enzyme readings and a higher risk score for fibrosis. However, the size of this association was tiny. When they looked at the data, the relationship explained less than one percent of the variation in liver health. To put this in perspective, if you were to look at the entire group of patients, knowing a person's vitamin D level would tell you almost nothing about their liver status. The strongest connection they found was not with the liver itself, but with a protein called albumin, which is a marker of general nutrition and inflammation. This suggested that low vitamin D was acting more like a general warning light for poor health rather than a specific trigger for liver disease.
To understand if vitamin D was truly causing the liver issues or just riding along with other problems, the team adjusted their calculations. They mathematically removed the influence of age, sex, kidney function, and crucially, the levels of albumin in the blood. Once they did this, the apparent link between vitamin D and liver scarring almost vanished. The remaining connection was so small that it would not change a single patient's diagnosis or treatment plan. In fact, the researchers calculated that even if a person increased their vitamin D by a significant amount, it would shift their liver risk score by a fraction of a point—far too little to move them from a low-risk category to a high-risk one. The study also checked for hidden tricks in the data, such as the fact that older people tend to have both lower vitamin D and higher liver risk scores naturally. Even after accounting for these factors, the vitamin D effect remained negligible.
The researchers also tested their methods by looking at other blood markers that vitamin D does not control, such as levels of sodium or potassium. They found that their statistical methods produced small, random-looking associations for these unrelated markers that were just as strong as the tiny link they found for vitamin D and the liver. This confirmed that the small signal they saw was likely just background noise created by the complexity of human health, rather than a specific biological effect of the vitamin. The study concludes that while low vitamin D is a reliable sign that a patient is not in peak health, it is not a driver of liver scarring. For doctors and patients, this means that measuring vitamin D levels will not help predict liver disease, and taking vitamin D supplements is unlikely to repair liver damage. The low vitamin D seen in sick patients is better understood as a symptom of their overall condition, not the cause of their liver problems.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.